Jae Ho Jeong
University of Ulsan
H-index: 17
Asia-South Korea
Top articles of Jae Ho Jeong
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15)
Therapeutic Advances in Medical Oncology
2024/1
Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trial
European Journal of Cancer
2024/1/1
Proteomic analysis of breast cancer based on immune subtypes
Clinical Proteomics
2024/12
Kyunggon Kim
H-Index: 13
Jae Ho Jeong
H-Index: 8
Comprehensive proteogenomic profiling and biomarker analyses in resected extrahepatic cholangiocarcinoma: A prespecified exploratory analysis of the phase 2 STAMP trial
Cancer Research
2024/3/22
Factors associated with engraftment success of patient-derived xenografts of breast cancer
Breast Cancer Research
2024/3/21
Jongwon Lee
H-Index: 3
Jae Ho Jeong
H-Index: 8
21‐gene expression assay and clinical outcomes of premenopausal patients with hormone receptor‐positive breast cancer
International Journal of Cancer
2024/2/15
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for immune checkpoint inhibitors in advanced biliary tract cancer
2024/1/10
Impacts of Subtype on Clinical Feature and Outcome of Male Breast Cancer: Multicenter Study in Korea (KCSG BR16-09)
Cancer Research and Treatment: Official Journal of Korean Cancer Association
2023/1
Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)
European Journal of Cancer
2023/12/1
Clinical practice recommendations for the use of next-generation sequencing in patients with solid cancer: a joint report from KSMO and KSP
Journal of Pathology and Translational Medicine
2023/11/29
Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer
European Journal of Cancer
2023/9/1
Randomized phase III trial of a neoadjuvant regimen of four cycles of adriamycin plus cyclophosphamide followed by four cycles of docetaxel (AC4-D4) versus a shorter treatment …
Breast Cancer Research and Treatment
2023/9
Jae Ho Jeong
H-Index: 8
Hak Hee Kim
H-Index: 27
Waiting Time for Breast Cancer Treatment in Korea: A Nationwide Cohort Study
Journal of Breast Cancer
2023/8
ERRATUM: Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision …
Cancer Research and Treatment: Official Journal of Korean Cancer Association
2023/7
Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
Cancer Research and Treatment: Official Journal of Korean Cancer Association
2023/7
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
Nature Cancer
2023/6
Utility of circulating tumor DNA (ctDNA) as a predictive biomarker for disease monitoring in patients (pts) with cholangiocarcinoma (CCA) before and during adjuvant …
2024/2/1
Treatment with liposomal irinotecan plus fluorouracil and leucovorin for patients with previously treated metastatic biliary tract cancer: the phase 2b NIFTY randomized …
JAMA oncology
2023/5/1
Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial
Hepatology
2023/5/1
Prediction of conversion surgery completion following neoadjuvant modified FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma: machine learning …
Cancer Research
2023/4/4
Jae Ho Jeong
H-Index: 8
Changhoon Yoo
H-Index: 23
